Answer to Question 1
4
Rationale: An epidural is administered above the dura.
Answer to Question 2
2
Rationale 1: Oprelvekin (Neumega) does not enhance the effectiveness of chemotherapy.
Rationale 2: Oprelvekin (Neumega) is used to stimulate the production of platelets in clients who are at risk for thrombocytopenia caused by cancer chemotherapy.
Rationale 3: Oprelvekin (Neumega) does not promote weight gain.
Rationale 4: Oprelvekin (Neumega) does not increase red blood cell count.
Global Rationale: Oprelvekin (Neumega) is used to stimulate the production of platelets in clients who are at risk for thrombocytopenia caused by cancer chemotherapy. Oprelvekin (Neumega) does not enhance the effectiveness of chemotherapy, promote weight gain, or increase red blood cell count.